HIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges HIMS Investors with Losses to Contact the Firm
1. Hims is facing class action lawsuits for misleading investors. 2. Allegations include selling illegitimate versions of Wegovy risking safety. 3. Possible termination of collaboration with Novo Nordisk is a concern. 4. Lead plaintiff deadline for investors is August 25, 2025. 5. Kessler Topaz Meltzer & Check is handling the lawsuits.